Filing Details

Accession Number:
0001169245-21-000046
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-24 18:11:07
Reporting Period:
2021-05-20
Accepted Time:
2021-05-24 18:11:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1169245 Phasebio Pharmaceuticals Inc PHAS Pharmaceutical Preparations (2834) 030375697
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1803271 Glen Burkhardt C/O Phasebio Pharmaceuticals, Inc.
1 Great Valley Parkway, Suite 30
Malvern PA 19355
Vp, Human Resources No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-05-20 3,811 $2.80 3,811 No 4 A Direct
Common Stock Disposition 2021-05-20 3,811 $3.29 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. These shares were acquired under the PhaseBio Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).